Mainz Biomed Executed Its Option From Uni Targeting Research To Acquire The Previously Licensed Scientific Intellectual Property For Its Flagship Product Coloalert, A Detection Test For Colorectal Cancer
The Company also exercised its exclusive option with SOCPRA Sciences Sante et Humaines S.E.C. to outright purchase intellectual property, including a pending patent, associated with a portfolio of novel gene
